Cargando…
Response of Bortezomib Chemotherapy in Hepatic Amyloidosis
Amyloidosis is a rare disorder with a wide spectrum of presentations and anomalies. It is subdivided into 2 broad categories based on protein deposition; primary and secondary amyloidosis. It can present as a single-organ involvement or as a diffuse infiltrative multi-organ process. Isolated hepatic...
Autores principales: | Hasan, Syed M., Ahmed, Nida N., Ahmed, Zunirah, Seibert, Allan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5846928/ https://www.ncbi.nlm.nih.gov/pubmed/29552568 http://dx.doi.org/10.1177/2324709618760079 |
Ejemplares similares
-
First Case of Nodular Localized Primary Cutaneous Amyloidosis Treated With Bortezomib and Dexamethasone
por: Khan, Noman Ahmed Jang, et al.
Publicado: (2021) -
Bortezomib Induced Hepatitis B Reactivation
por: Hussain, Salwa, et al.
Publicado: (2014) -
Effectiveness of Bortezomib in Cardiac AL Amyloidosis: A Report of Two Cases
por: Nigrelli, Santi, et al.
Publicado: (2014) -
Ventricular Fibrillation after Bortezomib Therapy in a Patient with Systemic Amyloidosis
por: Yamasaki, Satoshi, et al.
Publicado: (2013) -
Recurrent Syncope and Cardiac Arrest in a Patient with Systemic Light Chain Amyloidosis Treated with Bortezomib
por: Jaipaul, Navin, et al.
Publicado: (2016)